Lipid Dysfunction in Macrophages Implicated in Lung Fibrosis
Fibrosis is a dysfunction of tissue maintenance in which fibroblast cells build excessive extracellular matrix structures, like small-scale scars throughout a tissue, disruptive of structure and function. A full understanding of how fibrosis develops in the lung remains to be established, which is one of the reasons why curative therapies for idiopathic pulmonary fibrosis have yet to be created. Approaches involving the removal of senescent cells seem promising, but early and possibly useful senolytic drugs are low-cost generics and supplements, and so funds are not available for usefully large clinical trials. Here, researchers propose that lipid metabolism dysfunction leading to an accumulation of cholesterol in macrophages in lung tissue is the primary mechanism in the development of pulmonary fibrosis. They demonstrate that inducing this cholesterol accumulation generates fibrosis.
Macrophages are essential for lung homeostasis and repair after injury, yet they can also promote pathological remodeling. Although mechanisms that sustain fibrosis are increasingly well defined, the endogenous events that initiate fibrotic remodeling remain incompletely understood. We examined mice deficient in the intracellular sterol transporter ABCG1 and assessed the temporal relationship between macrophage lipid accumulation, collagen deposition, and fibrotic remodeling. Lipidomic profiling was performed on Abcg1-deficient macrophages and macrophages isolated during early experimental fibrosis. Candidate lipid species were tested for their ability to activate fibroblasts in vitro, and therapeutic interventions targeting macrophage cholesterol trafficking or fibroblast lipid uptake were evaluated in vivo.
Loss of ABCG1 caused lipid accumulation in alveolar macrophages early before collagen deposition and lung remodeling. Lipidomic analyses revealed conserved enrichment of polyunsaturated acyl tails within complex lipid species in Abcg1-deficient macrophages and macrophages from early-stage experimental fibrosis. These lipids directly activated fibroblasts and induced fibrotic gene expression in vitro. Restoration of macrophage cholesterol trafficking or inhibition of fibroblast lipid uptake prevented fibrotic remodeling in vivo.
Macrophage cholesterol dysregulation is sufficient to initiate spontaneous lung fibrosis. These findings identify a lipid-mediated macrophage-fibroblast axis as an endogenous driver of fibrotic remodeling and suggest that targeting macrophage lipid handling or fibroblast lipid uptake may represent a therapeutic strategy in fibrotic lung disease.